Briacell Therapeutics Corp BCTX

$BCTX https://youtu.be/5degIsw-fTI

$BCTX gap up coming sooner than we think

$BCTX we all come here to see if our fellow investors have anything new to share. Well the good news is that no news is the best news. Patience for a mid December read out would be wonderful, if mid January even better. Now that dilution off the table for awhile just sit back and relax. Key word Ample . I’m sure we will get some news on the full 354 enrollment relatively soon and prior to any 144 event news. Key word Hockey stick. IMO a great time to watch the technical pattern and add at support levels.

$BCTX Bria-IMT™ (lead candidate): In an ongoing pivotal Phase 3 trial (Bria-ABC / NCT06072612) for metastatic breast cancer, testing Bria-IMT ± immune checkpoint inhibitor vs. physician’s choice. The combination regimen has FDA Fast Track designation. An independent Data Safety Monitoring Board (DSMB) has repeatedly recommended the trial continue without modifications (most recent public updates in 2026). Overall survival is the primary endpoint, with an interim analysis planned after 144 deaths.  • Bria-BRES+™: FDA cleared the IND in May 2026, allowing initiation of a Phase 1/2a study in metastatic breast cancer. This is a next-generation personalized, off-the-shelf cell-based immunotherapy building on the Bria-OTS platform.  • Bria-PROS+™: FDA cleared the IND in August 2026, enabling a Phase 1/2a study in prostate cancer. It is also a next-generation personalized immunotherapy; the program previously received a $2M NCI grant. 

$CAPR $BCTX $VKTX $SLS $ABCL 50$ all of these 👆

$BCTX i have no luck with bios.

$NVAX $VKTX $HIMS $EBS $BCTX Bios undervalued All are BuYs here at these prices each of these should be above 50$

$BCTX $IOVA $VKTX $SLS $ABCL 4$ BCTX this is where you buy 12$ 🎯